Humana Inc. $HUM Stock Position Increased by Pzena Investment Management LLC

Pzena Investment Management LLC raised its holdings in Humana Inc. (NYSE:HUM) by 1.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,072,208 shares of the insurance provider’s stock after purchasing an additional 41,125 shares during the period. Humana accounts for approximately 3.2% of Pzena Investment Management LLC’s portfolio, making the stock its 9th largest holding. Pzena Investment Management LLC’s holdings in Humana were worth $1,043,015,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Illinois Municipal Retirement Fund raised its position in shares of Humana by 9.6% in the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after buying an additional 4,351 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Humana by 161.5% in the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after buying an additional 1,060,767 shares during the last quarter. National Pension Service raised its position in shares of Humana by 2.8% in the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock valued at $49,328,000 after buying an additional 5,150 shares during the last quarter. Long Focus Capital Management LLC acquired a new position in shares of Humana in the third quarter valued at approximately $34,212,000. Finally, Tejara Capital Ltd acquired a new position in shares of Humana in the third quarter valued at approximately $1,873,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HUM. Evercore boosted their price objective on shares of Humana from $195.00 to $250.00 in a research report on Thursday, April 30th. Robert W. Baird cut their price objective on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. UBS Group boosted their price objective on shares of Humana from $195.00 to $262.00 and gave the company a “neutral” rating in a research report on Thursday, April 30th. Royal Bank Of Canada boosted their price objective on shares of Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research report on Thursday, April 30th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Humana from $180.00 to $214.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Nine investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $260.83.

Humana Price Performance

Humana stock opened at $303.13 on Friday. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $315.66. The firm has a fifty day moving average of $215.40 and a 200-day moving average of $227.07. The firm has a market capitalization of $36.39 billion, a P/E ratio of 32.42, a PEG ratio of 2.83 and a beta of 0.68. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts predict that Humana Inc. will post 9 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana’s dividend payout ratio is 37.86%.

Insider Buying and Selling at Humana

In other news, insider Sanjay K. Shetty bought 810 shares of the firm’s stock in a transaction dated Monday, February 23rd. The stock was acquired at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the purchase, the insider owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.20% of the company’s stock.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.